• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus

tetano

Editor, Senior Moderator
Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4. [h=1]Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.[/h]
Baz M[SUP]1[/SUP], M'hamdi Z[SUP]2[/SUP], Carbonneau J[SUP]2[/SUP], Lavigne S[SUP]3[/SUP], Couture C[SUP]3[/SUP], Abed Y[SUP]2[/SUP], Boivin G[SUP]4[/SUP].
[h=3]Author information[/h] 1 Research Center in Infectious Diseases of the CHU of Qu?bec and Laval University, Qu?bec City, Qu?bec, Canada. mariana.baz@crchudequebec.ulaval.ca. 2 Research Center in Infectious Diseases of the CHU of Qu?bec and Laval University, Qu?bec City, Qu?bec, Canada. 3 Quebec Heart and Lung Institute, Department of Anatomopathology and Cytology, Laval University, Qu?bec City, Qu?bec, Canada. 4 Research Center in Infectious Diseases of the CHU of Qu?bec and Laval University, Qu?bec City, Qu?bec, Canada. Guy.Boivin@crchul.ulaval.ca.

[h=3]Abstract[/h] The mouse is the most widely used animal model for influenza virus research. However, the susceptibility of mice to seasonal influenza virus depends on the strain of mouse and on the strain of the influenza virus. Seasonal A/H3N2 influenza viruses do not replicate well in mice and therefore they need to be adapted to this animal model. In this study, we generated a mouse-adapted A/H3N2 virus (A/Switzerland/9715293/2013 [MA-H3N2]) by serial passaging in mouse lungs that exhibited greater virulence compared to the wild-type virus (P0-H3N2). Seven mutations were found in the genome of MA-H3N2: PA(K615E), NP(G384R), NA(G320E) and HA(N122D, N144E, N246K, and A304T). Using reverse genetics, two synergistically acting genes were found as determinants of the pathogenicity in mice. First, the HA substitutions were shown to enhanced viral replication in vitro and, second, the PA-K615E substitution increased polymerase activity, although did not alter virus replication in vitro or in mice. Notably, single mutations had only limited effects on virulence in vitro. In conclusion, a co-contribution of HA and PA mutations resulted in a lethal mouse model of seasonal A/H3N2 virus. Such adapted virus is an excellent tool for evaluation of novel drugs or vaccines and for study of influenza pathogenesis.


PMID: 31719554 DOI: 10.1038/s41598-019-51877-4
 
Back
Top Bottom